High sensitive immunophenotyping and DNA ploidy techniques for minimal residual disease investigation in multiple myeloma.

被引：0
|
作者：
Almeida, J
Orfao, A
Ocqueteau, M
Mateo, G
Corral, M
Caballero, D
Blade, J
San Miguel, JF
机构：
[1] Univ Hosp, Hematol Serv, Dept Med, Univ Salamanca, Salamanca, Spain
[2] Hosp Clin, Barcelona, Spain
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：98A / 98A
页数：1
相关论文
共 50 条
  • [1] High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma
    Almeida, J
    Orfao, A
    Ocqueteau, M
    Mateo, G
    Corral, M
    Caballero, MD
    Blade, J
    Moro, MJ
    Hernandez, J
    San Miguel, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) : 121 - 131
  • [2] Flow Cytometric Immunophenotyping for Minimal Residual Disease Analysis in Multiple Myeloma.
    Gupta, Rita
    Bhaskar, Archana
    Jain, Paresh
    Sharma, Atul
    Kumar, Lalit
    BLOOD, 2008, 112 (11) : 937 - 937
  • [3] Immunophenotype and DNA ploidy analysis:: Implications for minimal residual disease investigation in multiple myeloma
    San Miguel, JF
    Almeida, J
    Mateo, G
    Ocqueteau, M
    Caballero, MD
    García-Sanz, R
    González, M
    Bladé, J
    Moro, MJ
    Hernández, I
    Orfao, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 279 - 279
  • [4] Tumour markers for monitoring minimal residual disease in multiple myeloma.
    Rothwell, DG
    Kalakonda, N
    Norton, JD
    Hawkins, RE
    Chopra, R
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [5] Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
    Gupta, Ritu
    Bhaskar, Archana
    Kumar, Lalit
    Sharma, Atul
    Jain, Paresh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 728 - 732
  • [6] MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA: IMAGING TECHNIQUES
    Zamagni, E.
    Tacchetti, P.
    Pantani, L.
    Mancuso, K.
    Zannetti, B.
    Rocchi, S.
    Rizzello, I
    Caratozzolo, I
    Nanni, C.
    Fanti, S.
    Cavo, M.
    HAEMATOLOGICA, 2018, 103 : 1 - 2
  • [7] Clinical relevance and prognostic value of minimal residual disease in multiple myeloma.
    Terragna, C
    Martinelli, G
    Rossi, M
    Bonifazi, F
    Soverini, S
    Amabile, M
    Giannini, B
    Ottaviani, E
    Buonamici, S
    Zamagni, E
    Cellini, C
    Tosi, P
    Tura, S
    Cavo, M
    Baccarani, M
    BLOOD, 2002, 100 (11) : 599A - 599A
  • [8] Minimal residual disease clinical monitoring and depth of response in multiple myeloma.
    Martinez-Lopez, Joaquin
    Wong, Sandy Wai Kuan
    Shah, Nina
    Bahri, Natasha
    Zhou, Kaili
    Martin, Thomas G.
    Wolf, Jeffrey Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] IMMUNOPHENOTYPIC INSTABILITY IN MULTIPLE MYELOMA. IMPLICATIONS FOR MINIMAL RESIDUAL DISEASE DETECTION
    Colado, Enrique
    Alonso-Nogues, Eva
    Fanjul, Emilia
    Ramirez, Angel
    Rayon, Consolacion
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 451 - 451
  • [10] High sensitive immunophenotyping studies for monitoring minimal residual disease (MRD) post-transplant in multiple myeloma (MM) patients.
    Almeida, J
    Orfao, A
    Mateo, G
    Ocqueteau, M
    Corral, M
    Caballero, MD
    Vazquez, L
    Bladé, J
    Moro, MJ
    Hernández, J
    San Miguel, JF
    BONE MARROW TRANSPLANTATION, 1999, 23 : S132 - S132
12345